ArticleHeliyon2024

Metformin reduces new-onset atrial fibrillation risk rather than atrial fibrillation burden in type 2 diabetes patients: A case-control study.

Chongxia Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.